secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K
Filed at:   2022-06-08T23:59:59+00:00
Accession:  0001558370-22-010044
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azenta buys Barkey for €80M; expands cell & gene therapy cold-chain products
----------------------------------------------------------------------------

- Purchase price approx €80M (~$86M) for Barkey, a provider of controlled-rate thawing devices.
- Barkey reported ~€17M in revenue for the twelve months ended March 31, 2022.
- Deal expected to close early July 2022; Barkey's owners and COO to join Azenta.
- Acquisition expected accretive to non-GAAP earnings immediately and GAAP within first year.
- Extends Azenta's cold-chain portfolio into cell & gene therapy, serving over 100 CGT customers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000155837022010044/0001558370-22-010044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000155837022010044/azta-20220607x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-010044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer